ABOUT

MagCyte One is a device that takes advantage of nanotechnology and microfluidics to help diagnose cancer up to 4 years before they are detectable by regular imaging techniques as Computerized Tomography, X-ray, and others. Early detection allows for prompt surgical resection of the affected area, leading to a much favorable prognosis and a less likely tumor recurrence.

MagCyte One performs, a liquid biopsy, using only a simple blood sample (3-10 ml). With MagCyte One, early cancer detection is performed without resorting to, procedures where the patient is submitted to radiation, discomfort, pain or dangerous invasive techniques as X-Ray, endoscopy, colonoscopy, solid biopsy, or others. By avoiding these procedures MagCyte One is a valuable tool in the screening of large numbers of patients that belong to risk groups, and can profoundly alter the way therapies are being administered by determining their actual efficacy on each individual patient.

Contrary to common diagnostic techniques the liquid biopsy can be performed virtually at any time, and in any stage of the disease. Furthermore, in patients with advanced disease, and failing chemotherapy MagCyte’s liquid biopsy can identify new therapeutic targets and new chemotherapy regimens.

MagCyte One looks through millions of blood cells to find migrating Circulating Tumor Cells (CTC) which exist in the blood stream even in early stages of carcinogenesis (cancer growth). MagCyte One does this by filtering CTC’s from a full blood sample, marking them with targeting magnetic markers and analyzing them with its state-of-art magnetic sensors.

Studies indicate that screening patients from risk groups (with regular methodologies) can increase the average life expectancy of cancer patients by more than 20%, and reduce treatment cost up to 4 times. However, due to the complexity, cost, and potential harmfulness of available procedures, they are not yet implemented. By introducing MagCyte One, a painless and risk-free test, in regular oncology clinical procedures, these numbers can greatly improve, and many more lives will be saved!